Initial Management of Tachycardia and Tachypnea in Asthma Patients

Assessment and Treatment

• The initial management for tachycardia and tachypnea in an asthma patient should focus on high-flow oxygen administration, nebulized beta-agonists, and systemic corticosteroids to rapidly address the underlying bronchospasm and improve oxygenation 1, 2
• Severe asthma features include being too breathless to complete sentences in one breath, respiratory rate >25 breaths/min (adults) or >50 breaths/min (children), heart rate >110 beats/min (adults) or >140 beats/min (children), and peak expiratory flow (PEF) <50% of predicted normal or best 3, 4
• Life-threatening features include PEF <33% of predicted normal or best, silent chest, cyanosis, or feeble respiratory effort, exhaustion, confusion, or drowsiness, and bradycardia or hypotension (late signs) 3

Oxygen Therapy and Beta-Agonist Administration

• Administer high-flow oxygen (40-60%) via face mask, with a target oxygen saturation (SpO₂) >92% 1, 2, 5
• Administer salbutamol 10 mg or terbutaline 5 mg via oxygen-driven nebulizer, with alternative options for children and adults 1, 2, 6

Systemic Corticosteroids and Additional Measures

• Give prednisolone 30-60 mg orally or intravenous hydrocortisone 200 mg immediately, with adjusted doses for children 6, 1, 5, 4
• Add ipratropium 0.5 mg nebulized to the beta-agonist for adults, or 100 μg for children, in cases of life-threatening features 6, 5

Monitoring and ICU Transfer

• Continuously monitor heart rate, respiratory rate, oxygen saturation, and PEF, and consider ICU transfer if there is deteriorating PEF, worsening or persistent hypoxia, exhaustion, confusion, drowsiness, or coma, or respiratory arrest 1, 5
• Avoid sedatives and only give antibiotics if bacterial infection is present 6, 1